Trial Details
COMPLETEDBasic Information
| Clinical ID | c1033 |
|---|---|
| Identifier | NCT03945188 |
| Trial Title | Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Etrasimod|DRUG: Placebo |
Participant Information
| Sponsor | Arena Pharmaceuticals |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2019-06-13 |
|---|---|
| Primary Completion Date | 2022-02-08 |
| Completion Date | 2022-02-16 |